Evidence map›Paper›PMID 34613475›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study.

Carmen Sebastià, Alfredo Páez-Carpio, Elena Guillen, Blanca Paño, Joan Albert Arnaiz, Angel L M De Francisco, Carlos Nicolau, Laura Oleaga

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Novel Insights into Diabetic Kidney Disease.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Carmen SebastiàDepartment of Radiology, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain. msebasti@clinic.cat.
Alfredo Páez-CarpioDepartment of Radiology, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Elena GuillenDepartment of Nephrology, Hospital Clinic de Barcelona, Barcelona, Spain.
Blanca PañoDepartment of Radiology, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Joan Albert ArnaizDepartment of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
Angel L M De FranciscoDepartment of Nephrology, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Cantabria, Spain.
Carlos NicolauDepartment of Radiology, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Laura OleagaDepartment of Radiology, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Hospital Clínic de Barcelona · ESUniversidad de Cantabria · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundT he objective of this study is to evaluate oral hydration compared to intravenous (i.v.) hydration in the prevention of post-contrast acute kidney injury (PC-AKI) in the oncologic subgroup of patients with stage IIIb chronic kidney disease (CKD) included in the NICIR study referred for elective contrast-enhanced computed tomography (CE-CT). MATERIAL AND

methodsWe performed a retrospective subanalysis of the oncological subgroup (174/228 patients, 74%) from a continuous prospective database of patients included in the recently published non-inferiority NICIR study. Patients received prophylaxis against PC-AKI with either oral hydration (500 mL of water 2 h before and 2000 mL during the 24 h after CE-CT) or i.v. hydration (sodium bicarbonate (166 mmol/L) 3 mL/kg/h starting 1 h before and 1 mL/kg/h during the first hour after CE-CT). The primary outcome was to compare the proportion of PC-AKI in the first 48 to 72 h after CE-CT in the two hydration groups. Secondary outcomes were to compare persistent PC-AKI, the need for haemodialysis, and the occurrence of adverse events related to prophylaxis in each group.

resultsOf 174 patients included in the subanalysis, 82 received oral hydration and 92 received i.v. hydration. There were no significant differences in clinical characteristics or risk factors between the two study arms. Overall the PC-AKI rate was 4.6% (8/174 patients), being 3.7% in the oral hydration arm (3/82 patients) and 5.4% (5/92 patients) in the i.v. hydration arm. The persistent PC-AKI rate was 1.2% (1/82 patients) in the oral hydration arm and 3.3% (3/92 patients) in the i.v. hydration arm. No patient required dialysis during the first month after CE-CT or had adverse effects related to the hydration regime.

conclusionIn oncological patients with stage IIIb CKD referred for elective CE-CT, the rate of PC-AKI in those receiving oral hydration did not significantly differ from that of patients receiving i.v. hydration.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicContrast MediaHumansRetrospective StudiesRisk FactorsTomography, X-Ray ComputedContrast MediaAcute renal eventCancerComputed tomographyContrast-induced acute kidney injuryContrast-induced nephopathyIodinated contrast mediaIodine/adverse effectsWater

Identifiers

PMID34613475
OpenAlexW3202006605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.